In prostate cancer, for instance, the binding of PEDF to PEDF-receptor/phospholipase A2 at the plasma membrane leads to the upregulation of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ). This evidence concerns the gene PPARG and prostate cancer.